SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Morgan Stanley Initiates Coverage On Akoya Biosciences with Overweight Rating, Announces Price Target of $26

Morgan Stanley analyst Tejas Savant initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Overweight rating and announces Price Target of $26.

05/11/2021 06:42
Morgan Stanley analyst Tejas Savant initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Overweight rating and announces Price Target of $26.